1600 Participants Needed

Naloxone Training for Opioid Overdose

HJ
MH
KE
Overseen ByKatrin Ewald
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: University of Missouri-Columbia
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

What is the purpose of this trial?

The pervasive impact of the opioid epidemic has touched all layers of society for the past two decades, resulting in over 115 deaths daily and imposing annual costs of $78.5 billion. Responding swiftly to overdoses, akin to various medical emergencies, poses a significant challenge, particularly in geographically dispersed rural areas and densely populated urban settings. Effectively delivering the life-saving drug naloxone, which counteracts the effects of overdoses, necessitates a well-coordinated and cost-efficient response system. Simply opting for widespread distribution of naloxone, even with citizen involvement, proves to be a financially burdensome approach when compared to more targeted strategies. Moreover, obstacles such as limited access, inadequate or unavailable naloxone training, and delayed response times from emergency responders compound the problem. Addressing these issues, the proposed Opioid Rapid Response System (ORRS) project seeks to advance prevention science by adopting an innovative approach that incorporates technology and contemporary communication theory. The primary objective of the ORRS project is to mitigate opioid overdose deaths by enlisting and training citizens to administer naloxone in response to such events. Leveraging the PulsePoint health app, which connects citizens to cardiac events, the ORRS project will extend its capabilities to respond to overdose incidents. This initiative involves comprehensive development of ORRS, followed by a randomized clinical trial on a national scale to assess its effectiveness. The study aims to contribute to both prevention and implementation science by identifying optimal recruitment strategies and testing a model of online training. In pursuit of these objectives, the study is guided by the following Specific Aims: SA 1: Refine and complete the development of ORRS. SA 2: Conduct a randomized clinical trial to evaluate the effectiveness of the intervention. SA 3: Prepare ORRS for dissemination.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications.

What data supports the effectiveness of this treatment for opioid overdose?

Research shows that training people, including healthcare professionals and nonmedical personnel, on how to use naloxone (a drug that can reverse opioid overdoses) increases their knowledge and confidence in managing overdoses. This training has been effective in various settings, helping to prevent deaths from opioid overdoses.12345

Is naloxone training safe for humans?

Naloxone training programs have been widely implemented to help prevent opioid overdose deaths, and there is no evidence suggesting that these training programs are unsafe for participants. The focus of these programs is on education and skill-building, which are generally considered safe activities.45678

How is the Naloxone Training for Opioid Overdose treatment different from other treatments for opioid overdose?

This treatment is unique because it focuses on training individuals, including healthcare professionals and community members, to effectively respond to opioid overdoses using naloxone, a medication that can reverse the effects of an overdose. Unlike other treatments that may focus solely on medication administration, this approach emphasizes education and skill-building to empower more people to act in emergency situations.1491011

Research Team

HJ

Hye Jeong Choi

Principal Investigator

Univeristy of Missouri

MH

Michael Hecht

Principal Investigator

Real Prevention

Eligibility Criteria

This trial is for adults over 18 who live in communities using the PulsePoint app, speak English fluently, and can download and use apps on a smartphone. It's not suitable for those who don't meet these criteria.

Inclusion Criteria

I live in a PulsePoint community.
I can speak and understand English fluently.
I can use a smartphone and download apps.

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Development

Refine and complete the development of the Opioid Rapid Response System (ORRS)

Not specified

Training

Participants receive online Naloxone training or non-active opioid overdose response training

Up to 1 month

Follow-up

Participants are monitored for their intent to intervene, self-efficacy, response efficacy, knowledge, and concerns related to opioid overdose management

Up to 6 months

Treatment Details

Interventions

  • Non-active opioid overdose response training
  • Opioid Rapid Response System (ORRS) training
Trial Overview The study tests an Opioid Rapid Response System (ORRS) training against standard non-active opioid overdose response training to see if it improves naloxone administration during overdoses using the PulsePoint health app.
Participant Groups
2Treatment groups
Experimental Treatment
Placebo Group
Group I: ORRS training groupExperimental Treatment1 Intervention
Online Naloxone training
Group II: Waitlist groupPlacebo Group1 Intervention
Participants will receive non-active opioid overdose response training. Investigators will provide online training about opioid prevalence in US, opioid mechanism, side effect, and addiction. However, Investigators do not provide any knowledge about opioid overdose management and naloxone in this training. Once the project is completed, participants will receive online Naloxone training.

Non-active opioid overdose response training is already approved in United States, European Union, Canada for the following indications:

🇺🇸
Approved in United States as Naloxone for:
  • Reversal of opioid overdose
🇪🇺
Approved in European Union as Naloxone for:
  • Reversal of opioid overdose
🇨🇦
Approved in Canada as Naloxone for:
  • Reversal of opioid overdose

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Missouri-Columbia

Lead Sponsor

Trials
387
Recruited
629,000+

Findings from Research

Training healthcare professionals in managing opioid overdoses and administering naloxone significantly improved their knowledge and confidence, with scores increasing from an average of 18.3 to 21.2 out of 26 after training.
While the 'cascade method' of training was somewhat effective, challenges such as clinician time constraints and resource availability hindered broader implementation, highlighting the need for policy changes and enhanced educational programs in drug services.
Impact of training for healthcare professionals on how to manage an opioid overdose with naloxone: effective, but dissemination is challenging.Mayet, S., Manning, V., Williams, A., et al.[2015]
In a study of 1280 participants who recently used opioids or received opioid agonist treatment, 7% reported a recent non-fatal opioid overdose, highlighting the ongoing risk of overdose in this population.
Despite the association of benzodiazepine and hazardous alcohol use with increased risk of overdose, only 17% of participants had access to naloxone and 14% had received training, indicating a significant gap in overdose prevention resources that needs to be addressed.
Non-fatal opioid overdose, naloxone access, and naloxone training among people who recently used opioids or received opioid agonist treatment in Australia: The ETHOS Engage study.Conway, A., Valerio, H., Peacock, A., et al.[2021]
The train-the-trainer model for overdose education and naloxone distribution significantly increased participants' knowledge and confidence in teaching others, especially among those with no prior experience, as shown by a statistically significant improvement (p < .001).
Six months after training, participants successfully trained 243 new individuals, highlighting the effectiveness of this model in expanding the reach of naloxone education to combat the opioid overdose epidemic.
Impact of the take ACTION Train-the-Trainer model of opioid overdose education with naloxone distribution- who benefits?Dahlem, CH., Scalera, M., Chen, B., et al.[2021]

References

Impact of training for healthcare professionals on how to manage an opioid overdose with naloxone: effective, but dissemination is challenging. [2015]
Non-fatal opioid overdose, naloxone access, and naloxone training among people who recently used opioids or received opioid agonist treatment in Australia: The ETHOS Engage study. [2021]
Impact of the take ACTION Train-the-Trainer model of opioid overdose education with naloxone distribution- who benefits? [2021]
An Opioid Education Program for Baccalaureate Nursing Students. [2021]
Naloxone Training From Nonmedical Personnel: Benefits Before, During, and After Overdose Events. [2021]
One opioid user saving another: the first study of an opioid overdose-reversal and naloxone distribution program addressing hard-to-reach drug scenes in Denmark. [2020]
Developing the Opioid Rapid Response System™ for Lay Citizen Response to the Opioid Overdose Crisis: a Randomized Controlled Trial. [2023]
Evaluation of the Overdose Education and Naloxone Distribution Program of the Baltimore Student Harm Reduction Coalition. [2022]
Prevalence and disparities in opioid overdose response training among people who inject drugs, San Francisco: Naloxone training among injectors in San Francisco. [2021]
10.United Statespubmed.ncbi.nlm.nih.gov
Implementation of an Opioid Overdose and Naloxone Distribution Training in a Pharmacist Laboratory Course. [2023]
A pilot study to compare virtual reality to hybrid simulation for opioid-related overdose and naloxone training. [2020]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security